Boca Biolistics
Boca Bio is a global leader in biospecimen procurement, clinical research services, and central laboratory testing, dedicated to supporting medical breakthroughs and advancing healthcare through innovative, high-quality, and ethically sourced biospecimens and comprehensive research solutions. The company offers a wide range of biospecimen management services, including biostorage, inventory, and custom procurement, with a focus on high-quality, well-annotated samples for diverse research needs.
Industries
Nr. of Employees
small (1-50)
Products
PBMC biospecimen aliquots
Clinically collected peripheral blood mononuclear cell (PBMC) aliquots processed same-day, cryopreserved and supplied with documentation of cell counts, pre-freeze viability targets, anticoagulant type, and donor clinical annotations.
Annotated biospecimen inventory
Large curated inventory of ethically collected human biospecimens across multiple specimen types with associated clinical, laboratory and molecular annotations used to support assay development, validation, and biomarker research. Inventory size is cited as over one million biospecimens sourced from 120+ global collection sites.
Bio-Rad CFX96 Touch™
Real-Time PCR detection system.
Bio-Rad Geenius™ Reader
Automated reading and interpretation system for western blot assays.
BD Max™ System
Fully automated molecular system for a broad range of tests. Streamlines workflow and increases laboratory efficiency with benchtop design.
BD MAX™ CPO
Healthcare-associated infections testing assay for the BD MAX System.
PBMC biospecimen aliquots
Clinically collected peripheral blood mononuclear cell (PBMC) aliquots processed same-day, cryopreserved and supplied with documentation of cell counts, pre-freeze viability targets, anticoagulant type, and donor clinical annotations.
Annotated biospecimen inventory
Large curated inventory of ethically collected human biospecimens across multiple specimen types with associated clinical, laboratory and molecular annotations used to support assay development, validation, and biomarker research. Inventory size is cited as over one million biospecimens sourced from 120+ global collection sites.
Bio-Rad CFX96 Touch™
Real-Time PCR detection system.
Bio-Rad Geenius™ Reader
Automated reading and interpretation system for western blot assays.
BD Max™ System
Fully automated molecular system for a broad range of tests. Streamlines workflow and increases laboratory efficiency with benchtop design.
BD MAX™ CPO
Healthcare-associated infections testing assay for the BD MAX System.
Services
Prospective and retrospective procurement of annotated human biospecimens tailored to study inclusion/exclusion criteria and molecular/clinical data requirements.
Secure storage and inventory services across ambient to ultra-low and liquid nitrogen conditions with real-time LIMS monitoring, controlled access, emergency power protections, and traceable sample retrieval.
Accredited molecular and immunological testing including routine and specialized assays, high-throughput PCR processing, and customizable test menus for validation and clinical studies.
End-to-end study design and execution for method comparison, validation, and precision/reproducibility testing with tailored statistical reporting and data exports for regulatory submissions.
Project management, site identification, site management, regulatory coordination, and data management to support clinical studies from feasibility through execution.
Secure LIMS-based data management, client portals for real-time access, options to interface with client LIS/EHR/EMR, and secure e-consent management.
Prospective and retrospective procurement of annotated human biospecimens tailored to study inclusion/exclusion criteria and molecular/clinical data requirements.
Secure storage and inventory services across ambient to ultra-low and liquid nitrogen conditions with real-time LIMS monitoring, controlled access, emergency power protections, and traceable sample retrieval.
Accredited molecular and immunological testing including routine and specialized assays, high-throughput PCR processing, and customizable test menus for validation and clinical studies.
End-to-end study design and execution for method comparison, validation, and precision/reproducibility testing with tailored statistical reporting and data exports for regulatory submissions.
Project management, site identification, site management, regulatory coordination, and data management to support clinical studies from feasibility through execution.
Secure LIMS-based data management, client portals for real-time access, options to interface with client LIS/EHR/EMR, and secure e-consent management.
Expertise Areas
- Biospecimen procurement and biobanking
- Biorepository operations and controlled biostorage (ambient to cryogenic)
- Global specimen collection network management
- Central laboratory molecular and immunoassay testing
Key Technologies
- Laboratory Information Management Systems (LIMS)
- Cryogenic storage (liquid nitrogen) and ultra-low temperature freezers (-80°C)
- Ambient and refrigerated storage (-20°C, controlled ambient)
- 24/7 environmental monitoring and alarm systems
News & Updates
Boca Biolistics partnered with Clairvest Group Inc., a Canadian private equity firm, with a $25 million investment to accelerate growth and expand operations in biopharmaceutical and life sciences industries.
An overview of Boca Bio's mission, services, and commitment to global healthcare innovation, including biospecimen sourcing, clinical research, and laboratory testing.
White paper discussing the latest variants of SARS-CoV-2 and their implications for diagnostics and research.
Research article on dengue virus detection and subtyping across multiple countries, supported by Boca Bio.
Study on innovative mHealth diagnostics using CRISPR/CAS technology, supported by Boca Bio.
Boca Biolistics partnered with Clairvest Group Inc., a Canadian private equity firm, with a $25 million investment to accelerate growth and expand operations in biopharmaceutical and life sciences industries.
An overview of Boca Bio's mission, services, and commitment to global healthcare innovation, including biospecimen sourcing, clinical research, and laboratory testing.
White paper discussing the latest variants of SARS-CoV-2 and their implications for diagnostics and research.
Research article on dengue virus detection and subtyping across multiple countries, supported by Boca Bio.
Study on innovative mHealth diagnostics using CRISPR/CAS technology, supported by Boca Bio.